Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) — Stella

Recruiting

Back to Primary Biliary Cholangitis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Xijing Hospital, Xi'an, Shaanxi

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Xijing Hospital of Digestive Diseases

Enrollment target

~117 participants

Started

April 2017

Primary completion

April 2027

Age range

18 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov